Ann: RMIT and MGC Pharmaceuticals Sign Strategic Agreement, page-2

Essentially a progress update on the MOU. Good news that will be received warmly but nothing groundbreaking. However, the one point of interest is this:

"MXC Australian Cultivation License Under MXC’s Australian medicinal cannabis research and cultivation license to be submitted to the Office of Drug Control, which has now been finalized with the execution of the Umbrella Agreement, RMIT and MXC will also begin pre-clinical trials to investigate the positive effects of medicinal cannabis on melanoma. Once the MXC cultivation license is obtained, the pre-clinical research will commence at RMIT’s state-of-the-art facilities in Melbourne. MXC will fund the research and all IP resulting from the trials will belong to MXC, which it will then seek to patent with IP Australia"

It seems the execution of this agreement was one of the things holding up the licence stuff.